ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,109,681 | +25.6% | 439,517 | +96.6% | 0.00% | – |
| Q2 2023 | $1,679,108 | +50.6% | 223,583 | -9.4% | 0.00% | – |
| Q1 2023 | $1,115,002 | -33.1% | 246,682 | +66.7% | 0.00% | – |
| Q4 2022 | $1,667,385 | -37.9% | 147,949 | -47.3% | 0.00% | -100.0% |
| Q3 2022 | $2,686,000 | +98.5% | 280,586 | +67.8% | 0.00% | – |
| Q2 2022 | $1,353,000 | -45.4% | 167,255 | +14.1% | 0.00% | – |
| Q1 2022 | $2,478,000 | +14.8% | 146,630 | +46.1% | 0.00% | – |
| Q4 2021 | $2,158,000 | -75.3% | 100,374 | -15.2% | 0.00% | -100.0% |
| Q3 2021 | $8,747,000 | +257.6% | 118,419 | +164.7% | 0.00% | – |
| Q2 2021 | $2,446,000 | -61.4% | 44,736 | -48.0% | 0.00% | -100.0% |
| Q1 2021 | $6,343,000 | -74.0% | 86,013 | -69.6% | 0.00% | -83.3% |
| Q4 2020 | $24,417,000 | – | 283,256 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $716,436,000 | 71.38% |
| Logos Global Management LP | 3,156,981 | $233,175,000 | 16.81% |
| Vivo Capital, LLC | 4,220,048 | $311,693,000 | 14.00% |
| Cormorant Asset Management, LP | 1,012,079 | $74,752,000 | 3.04% |
| Redmile Group, LLC | 864,435 | $63,847,000 | 1.11% |
| Nan Fung Group Holdings Ltd | 41,950 | $3,098,000 | 0.99% |
| Artal Group S.A. | 500,000 | $36,930,000 | 0.83% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,706 | $9,506,000 | 0.80% |
| Pier Capital, LLC | 75,362 | $5,566,000 | 0.58% |
| Financial Advisory Group | 31,417 | $2,320,000 | 0.51% |